International law firm Linklaters has provided legal counsel in the landmark US$813 million acquisition financing of Aster DM Healthcare’s GCC business. The transaction saw a consortium of regional financiers providing acquisition financing facilities to a consortium led by Fajr Capital for the acquisition of Aster’s GCC Business. With an enterprise value exceeding US$1.7 billion, this […]
Appointments
Healthcare, Pharma & Life Sciences
United Arab Emirates
Shatha Bakhsh Promoted to Director at Align Technology
In a recent LinkedIn announcement, Shatha Bakhsh (pictured) shared her promotion to Director, Managing Counsel Middle East, Turkey, and Africa at Align Technology, a global medical device company. Bakhsh, who is a Member of Europe,
Capital Markets
Healthcare, Pharma & Life Sciences
Other
Farj Capital Consortium Secures Majority Stake in Aster DM
ASAR – Al Ruwayeh & Partners acted as local legal counsel alongside Allen & Overy as lead counsel, in facilitating the acquisition of a 65% stake in Aster DM Healthcare FZC, the holding company overseeing Aster DM
Banking & Finance
Competition & Antitrust
Healthcare, Pharma & Life Sciences
United Arab Emirates
Eversheds Advises on DIB’s Resolution with NMC Healthcare
Eversheds Sutherland has provided legal counsel to Dubai Islamic Bank (DIB), one of the leading Islamic banks in the UAE, in reaching a comprehensive settlement with NMC Healthcare group (NMC), a prominent integrated private healthcare
Healthcare, Pharma & Life Sciences
Other
Restructurings
Freshfields Guides 3M Through Solventum Spin-Off
Global law firm Freshfields Bruckhaus Deringer (‘Freshfields’) has provided legal counsel to the US-based technology conglomerate 3M in its spin-off of the healthcare division, now known as Solventum, which is listed on the New York
Healthcare, Pharma & Life Sciences
IPOs
Saudi Arabia
Dr. Soliman Abdul Kader Fakeeh Hospital IPO Cleared by CMA
The Capital Market Authority (CMA) has granted its approval for the registration and initial public offering (IPO) of shares of Dr. Soliman Abdul Kader Fakeeh Hospital Company. This decision, made by the CMA Board on 17/09/1445
Corporate
Healthcare, Pharma & Life Sciences
United Arab Emirates
ADQ Launches Arcera: Driving Healthcare Evolution
ADQ, the prominent Abu Dhabi-based investment and holding company, has introduced Arcera, a new global holding company headquartered in Abu Dhabi, UAE, dedicated to the life sciences sector. Arcera aims to pioneer advancements in healthcare,
Capital Markets
Egypt
Healthcare, Pharma & Life Sciences
MBH Advises Admaius on Parkville Stake Acquisition
Matouk Bassiouny & Hennawy (MBH) served as legal counsel to Admaius Capital Partners (Admaius), a prominent African-focused private equity fund, in its acquisition of a significant minority stake in Parkville Holding B.V. (Parkville) and
Banking & Finance
Competition & Antitrust
Healthcare, Pharma & Life Sciences
United Arab Emirates
NMC and Dubai Islamic Bank Reach Amicable Resolution
NMC Healthcare group (“NMC”), a prominent private healthcare provider in the United Arab Emirates (“UAE”), and Dubai Islamic Bank (“DIB”), one of the largest Islamic banks in the UAE, have announced the successful resolution of
Banking & Finance
Capital Markets
Deal & transactions
Egypt
Healthcare, Pharma & Life Sciences
ADSERO Facilitate Investment in Parkville Pharmaceutical
Parkville Pharmaceutical Secures Significant Minority Investment from Admaius Capital Partners ADSERO – Ragy Soliman & Partners have successfully advised Parkville Pharmaceutical on a significant minority investment from Admaius Capital Partners. The advisory team from ADSERO – Ragy
